Eastern Hepatobiliary Surgery Hospital
A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells
- Conditions
- Interventions
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 184
- Registration Number
- NCT04521491
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2020-06-17
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 56
- Registration Number
- NCT04386772
- Locations
- 🇨🇳
Easter hepatobiliary surgery hospital, Shanghai, Shanghai, China
Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma
- First Posted Date
- 2018-10-11
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 138
- Registration Number
- NCT03702491
- Locations
- 🇨🇳
xiao qing xiao qing Jiang, Shanghai, Shanghai, China
Prospective Surveillance for Very Early Hepatocellular Carcinoma
- Conditions
- First Posted Date
- 2018-07-17
- Last Posted Date
- 2020-05-22
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT03588442
- Locations
- 🇨🇳
The First Hospital Affiliated to AMU (Southwest Hospital), Chongqing, Chongqing, China
🇨🇳Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
🇨🇳Mengchao Hepatobiliary Surgery Hospital of Fujian Medical University, Fuzhou, Fujian, China
Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2018-05-03
- Last Posted Date
- 2018-05-03
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 459
- Registration Number
- NCT03515369
Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 4005
- Registration Number
- NCT03047603
- Locations
- 🇨🇳
Eastern hepatobiliary surgery hospital, Shanghai, Shanghai, China
Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion
- Conditions
- Interventions
- First Posted Date
- 2016-04-05
- Last Posted Date
- 2016-04-05
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT02728219
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Standard Treatments of Very-early Stage Hepatocellular Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2016-04-05
- Last Posted Date
- 2016-04-05
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT02728193
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology
- First Posted Date
- 2016-04-04
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT02727673
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China
Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT02724332
- Locations
- 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China